Marijke Scholten

Autologous and Allogeneic Stem-Cell Transplantation for Transformed Chronic Lymphocytic Leukemia (Richter's Syndrome): A Retrospective Analysis From the Chronic Lymphocytic Leukemia Subcommittee of the Chronic Leukemia Working Party and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Kate Cwynarski, Anja van Biezen, Liesbeth C. de Wreede et al. · Journal of Clinical Oncology · 2012 · 132 citations · Full text

Medicine, Hematology, Oncology +13

Should the standard dimethyl sulfoxide concentration be reduced? Results of a <scp>E</scp>uropean <scp>G</scp>roup for <scp>B</scp>lood and <scp>M</scp>arrow <scp>T</scp>ransplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide

Curly Morris, Liesbeth C. de Wreede, Marijke Scholten et al. · Transfusion · 2014 · 94 citations · Full text

Medicine, Oncology, Cell Therapy +14

Allogeneic hematopoietic stem cell transplantation in patients with polycythemia vera or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia: a report from the MPN Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation

Federico Lussana, Alessandro Rambaldi, Maria Chiara Finazzi et al. · Haematologica · 2014 · 72 citations · Full text

Medicine, Hematology, Internal Medicine +17

Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT

Eline M.P. Cremers, Anja van Biezen, Liesbeth C. de Wreede et al. · Annals of Hematology · 2016 · 21 citations · Full text

Medicine, Hematology, Hematologic Oncology +13